Han Shaowei, Ph.D., serves as the Director of Innovation Drug Project & Business Development at Youcare Pharmaceutical Group Co., Ltd. He has long focused on the latest developments in small nucleic acid drugs, mRNA vaccines, viral membrane fusion inhibitors, and peptide drugs for cell and gene therapy. He has helped the company secure approval for 15 Class 1 new drug projects and successfully completed one license-in project. Among these, 2 IND applications have been approved in China, 4 in the United States, and 1 in Australia. These projects are currently in the Phase III clinical trial stage.